Medco Gets Personal: LabCorp Agreement Pairs Cancer Med With AmpliChip
This article was originally published in The Gray Sheet
Executive Summary
The pharmacy benefit manager Medco is working with the Laboratory Corporation of America to develop data on a personalized medicine approach to the use of the breast cancer drug tamoxifen
You may also be interested in...
Is Data Adequate To Support Warfarin Dosing Test Coverage? Comments Vary
Stakeholder opinions on whether Medicare should cover warfarin dosing tests vary based on the commenters' views on the adequacy of existing data
Is Data Adequate To Support Warfarin Dosing Test Coverage? Comments Vary
Stakeholder opinions on whether Medicare should cover warfarin dosing tests vary based on the commenters' views on the adequacy of existing data
Genomic Updates To Drug Labeling Could Boost Gene Testing
FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information